Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””

Mie Balling; Anne Langsted; Shoaib Afzal; Anette Varbo; George Davey Smith; Børge G. Nordestgaard

doi:10.1016/j.atherosclerosis.2020.03.027

Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””

Mie Balling, Anne Langsted, Shoaib Afzal, Anette Varbo, George Davey Smith, Børge G. Nordestgaard^*

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

2 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Atherosclerosis
Vol/bind	302
Sider (fra-til)	57-58
Antal sider	2
ISSN	0021-9150
DOI	https://doi.org/10.1016/j.atherosclerosis.2020.03.027
Status	Udgivet - 2020

Adgang til dokumentet

10.1016/j.atherosclerosis.2020.03.027

OpenUrl tilgængelighed

Fuld tekst

Citationsformater

@article{56d43e93fa8d4fbf8bdc2f5a004ba5ee,

title = "Reply to: “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””",

keywords = "Atherosclerotic, Cardiovascular disease, Cholesterol, Lipoproteins, Nuclear magnetic resonance",

author = "Mie Balling and Anne Langsted and Shoaib Afzal and Anette Varbo and {Davey Smith}, George and Nordestgaard, {B{\o}rge G.}",

year = "2020",

doi = "10.1016/j.atherosclerosis.2020.03.027",

language = "English",

volume = "302",

pages = "57--58",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Reply to

T2 - “Methodological issues regarding: “A third of nonfasting plasma cholesterol is in remnant lipoproteins: Lipoprotein subclass profiling in 9293 individuals””

AU - Balling, Mie

AU - Langsted, Anne

AU - Afzal, Shoaib

AU - Varbo, Anette

AU - Davey Smith, George

AU - Nordestgaard, Børge G.

PY - 2020

Y1 - 2020

KW - Atherosclerotic

KW - Cardiovascular disease

KW - Cholesterol

KW - Lipoproteins

KW - Nuclear magnetic resonance

U2 - 10.1016/j.atherosclerosis.2020.03.027

DO - 10.1016/j.atherosclerosis.2020.03.027

M3 - Comment/debate

C2 - 32331771

AN - SCOPUS:85085901774

SN - 0021-9150

VL - 302

SP - 57

EP - 58

JO - Atherosclerosis

JF - Atherosclerosis

ER -